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INTRODUCTION
Squamous cell carcinoma of the head and neck spreads via
the lymphatics to cervical lymph nodes, but controversy re-
mains about the best means to determine the nodal status of
these patients. Clinical examination and radiologic imaging
techniques are relatively inaccurate for staging the neck, and
the nodal status can only be determined accurately following
a neck dissection (1-3). 
Several authors have shown that if the first draining lymph
node has no evidence of micrometastases on histologic exami-
nation, the incidence of metastases to the remaining lympha-
tic basin in cutaneous melanoma and head and neck cancer
is less than 5% (4, 5). This has led to sentinel lymph node
biopsy (SLNBx) becoming an accepted technique for deter-
mining whether metastases are present in the first echelon
of draining lymph nodes in patients with head and neck can-
cer (6). SLNBx has allowed these patients to avoid procedu-
ral morbidity while undergoing elective neck dissection for
their malignancies. 
Recent studies on sentinel lymph node localization in head
and neck squamous cell carcinoma have revealed a localiza-
tion rate of 97% (95% confidence interval, 94-100%), an
average micrometastatic rate to sentinel lymph nodes of 31%
(95% confidence interval, 23-39%), and a false negative rate
of 2.4% (95% confidence interval, 0-5%) (3, 4, 7-10).
The clinical application of this potentially valuable proce-
dure as a sole diagnostic tool to stage the nodal status requires
its standardization at each institute, because results report-
edly vary according to the scanning techniques, the materi-
als for localization and the method of histological examina-
tion (4). Therefore, multi-institutional clinical trials are cur-
rently determining the diagnostic accuracy of uniform SLNBx
techniques such as ‘American College of Surgeons Oncology
Group protocol Z0360’, and there is a growing consensus
that a diagnostic procedure to detect cancer cells in the sen-
tinel lymph node is an effective method for staging lymph
node metastasis of head and neck cancers. 
The primary objective of this study was to evaluate the fea-
sibility of SLNBx by using a radiotracer lymphatic mapping
technique in patients with squamous cell carcinoma of the
oral cavity. A secondary objective was to determine whether
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Sentinel Lymph Node Radiolocalization with 
99mTc Filtered Tin Colloid
in Clinically Node-Negative Squamous Cell Carcinomas of the Oral
Cavity
The objective of this study was to evaluate the feasibility of sentinel lymph node bio-
psy by using a radiotracer lymphatic mapping technique in patients with squamous
cell carcinoma of the oral cavity, and the diagnostic value of this technique. We stud-
ied twenty patients with previously untreated squamous cell carcinomas of the oral
cavity and N0 necks. After the peritumoral injection of 
99mTc filtered tin colloid preop-
eratively, lymphoscintigraphy and intraoperative mapping using a gamma detector
were performed to localize sentinel nodes. An open biopsy of the sentinel node was
followed by complete neck dissection. We identified the sentinel nodes in 19 of 20
patients (95.0%) by lymphoscintigraphy and in all (100%) by intraoperative gamma
detector. In all cases, the status of the sentinel node accurately predicted the patho-
logic status of the neck with the false negative rate being 0%. The negative predic-
tive value for the absence of cervical metastases was 100%. In conclusion, our radio-
localization technique of sentinel nodes using 
99mTc filtered tin colloid in N0 squa-
mous cell carcinomas of the oral cavity is technically feasible and appears to accu-
rately predict the presence of the occult metastatic disease.
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the histopathologic status of the sentinel node predicts the
status of the other regional lymph nodes. This study could
serve as the primary protocol of the SLNBx procedure in head
and neck cancer for further ongoing clinical trials.
MATERIALS AND METHODS
From 2002 through 2005, we enrolled 20 consecutive pa-
tients, 15 men and 5 women, aged from 35 to 68 yr (mean:
53 yr) (Table 1). The eligibility criteria for participation in
this prospective study were a diagnosis of previously untreat-
ed, biopsy-proven squamous cell carcinoma of the oral cavity
and no evidence of cervical lymph node metastasis by clinical
and computed tomography evaluation. Primary sites other
than the oral cavity were excluded because their relative inac-
cessibility made precise injections around the primary site
difficult. The primary tumor was located in the oral tongue
in 19 patients and in the buccal mucosa in 1 patient. The
application of the elective neck dissection was directed for a
primary tumor depth of greater than 5 mm in stage T1 and
any tumor in stage T2 or higher. As for the depth of primary
lesion, the authors evaluated the primary lesion of the sub-
jects by two methods: physical examination and radiological
evaluation. Careful palpation was routinely performed at each
examination and more importantly under general anesthesia
before the definite resection. Also we evaluated the lesion by
contrast enhanced CT or MRI, which partly provided the
information about the depth of primary lesion. When the
physical palpation reveals that the lesions of the oral cavity
are put on the mucosal layer only, and that the lesions show
their movement apart from the submucosal structure such
as intrinsic muscles without fixation, the authors regarded
the depth of lesion as less than 5 mm. In addition, if the only
superficial thickening and superficial enhancement of lesions
was noted in the preoperative radiological study (CT or MRI),
the depth of lesion was thought to be less than 5 mm. In case
of the infiltration to the submucosal tissue, we performed
the elective neck dissection for those subjects.
All patients underwent selective neck dissection removing
levels I - III or I - IV of the cervical lymph node groups after
the application of SLNBx prodecure. The difference of the
extent of neck dissection (with or without level IV) mainly
depended on the results of the preoperative SLNBx procedure.
If the sentinel lymph node was found in level IV lymph node
groups with the result of SLNBx procedure, the surgeon took
out the level IV lymph node group as well as the level I to
III (Case number 9, 13, and 19 in Table 1). The SLNBx pro-
cedure was explained in detail to all patients, who subsequen-
tly provided their informed consent. The Institutional Review
Board of Samsung Medical Center approved the protocol for
this study.
On the day prior to surgery, patients attended the Depart-
ment of Nuclear Medicine for the peritumoral injection of
the radioacitive tracer (Fig. 1). The radioactive tracer used
was technetium 99m (99mTc) prepared with tin colloid (Amer-
scanTM Hepatate IITM agent, Nycomed Amersham Health Inc.,
London, U.K.) and filtered so that the particles were less than
200 nm. The tracer (5-6 mCi in 0.6 mL) was injected sub-
mucosally around the circumference of the primary tumor.
For 1 hr after the injection, dynamic lymphoscintigraphy was
performed every 5 min in the anterior and lateral views and
Case
No.
Sex/
Age 
(yr)
Primary
site
Tumor
stage
No. pos-
tive
nodes/
No. dis-
sected
nodes
SLN
No.
Neck
level
Patho-
logic
status
1 M/62 T T2 3 I,II (-) 0/48
2 M/68 T T2 1 II (-) 0/17
3 M/48 T T1 3 III (-) 0/24
4 M/42 T T1 1 II (-) 0/23
5 M/46 B T1 2 II (-) 0/19
6 M/45 T T2 2 II,III III(+) 1/20
7 F/62 T T1 4 I,II,III (-) 0/42
8 F/68 T T1 1 II II(+) 1/31
9 M/57 T T1 3 II,III,IV (-) 0/26
10 M/43 T T2 3 I,II (-) 0/56
11 M/50 T T2 2 II,III II(+) 1/30
12 M/67 T T2 4 I,II,III I(+) 1/26
13 M/49 T T1 3 II,III,IV (-) 0/36
14 F/58 T T2 2 I,II I(+),II(+) 3/37
15 F/57 T T1 4 II,III (-) 0/12
16 M/40 T T1 3 I,II,III (-) 0/15
17 M/35 T T1 3 II,III II(+) 3/30
18 M/55 T T1 1 II (-) 0/15
19 M/42 T T1 4 II,III,IV (-) 0/9
20 F/65 T T1 2 I,II (-) 0/9
Table 1. Patient profiles and the results of sentinel lymph node
biopsy
SLN, sentinel lymph node; T, tongue; B, buccal mucosa.
Fig. 1. The peritumoral injection of the radioacitive tracer. 
99mTc fil-
tered tin colloid (5-6 mCi in 0.6 mL) was injected submucosally
around the circumference of the primary tumor. then until 2 hr prior to surgery at an interval of 3-6 hr, with
static images obtained to monitor the residual radioactivity
(Fig. 2). 
Intraoperatively, all radioactive lymph nodes were identi-
fied with a handheld gamma probe (Navigator GPS, Tyco
Health Care, Mansfield, MA, U.S.A.) that was used to iden-
tify radioactive sentinel nodes (Fig. 3), including those marked
preoperatively through the surface by lymphoscintigraphy.
To reduce the detection of radiation from the injection site,
the primary tumor was removed first with an adequate resec-
tion margin according to current accepted treatment standards.
After localization on the skin surface, the skin flaps for elec-
tive neck dissection were raised and the hand held gamma
probe (sterilely wrapped) was used to precisely identify any
radioactive nodes (Fig. 4). Lymph nodes with radioactivity
counts greater than threefold the background counts were
considered the sentinel lymph nodes (4, 9) We also adopted
the following criteria for these lymph nodes: 1) the highly
radioactive in vivo before incision, 2) the highly radioactive
ex vivo, and 3) decreased radioactivity in the lymphatic bed
after removal of the highly radioactive node (9). After removal
of sentinel lymph nodes, all patients then received elective
neck dissection. 
Sentinel nodes were labeled according to their radioactivity
and anatomic lymph node level after the radioactivity with-
in the node was confirmed ex vivo (Fig. 5). The sentinel nodes
were divided into three equal levels through their longest axis
and frozen with Optimal Cutting Temperature compound
separately. One section for each block was evaluated using
frozen section analysis with hematoxylin-eosin staining. 
After frozen section diagnosis, frozen tissue blocks were
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Fig. 3. The handheld gamma probe (Navigator GPS, Tyco Health
Care, Mansfield, MA, U.S.A.). The handheld gamma probe was
used to identify radioactive sentinel nodes, including those marked
preoperatively through the surface by lymphsocintigraphy.
Fig. 4. The detection of sentinel node using a handheld gamma
probe. After localization on the skin surface, the skin flaps for elec-
tive neck dissection are raised and the hand held gamma probe
(sterilely wrapped) is used to precisely identify any radioactive
nodes.
Fig. 5. Confirma-
tion of the radio-
activity of senti-
nel nodes ex vi-
vo. Sentinel no-
des were labeled
according to their
radioactivity after
the radioactivity
within the node
was confirmed
ex vivo. 
Fig. 2. Lymphoscintigraphy after the peritumoral injection. For 1 hr
after the injection, dynamic lymphoscintigraphy was performed
every 5 min in the anterior and lateral views and then until 2 hr prior
to surgery at an interval of 3-6 hr, with static images obtained to
monitor the residual radioactivity. 
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melt, fixed in 10% neutral buffered formalin, and embed-
ded in paraffin. These paraffin blocks were serially sectioned
at 250  m, and then six sections from each level within the
block were prepared with hematoxylin-eosin stainings and
examined for possible metastasis. If the node still appeared
free from tumors, immunohistochemical analysis for cyto-
keratin (AE1/AE3) was performed. Cytokeratin positivity
was compared with the adjacent serial section stained with
hematoxylin-eosin to confirm that it represented viable tumor
cells. The full pathological protocol was used to examine nodes
that appeared negative following frozen section hematoxylin-
eosin analysis. The incidences of metastases in the sentinel
lymph nodes and the remaining lymphadenectomy specimen
were compared.
RESULTS
SLNBx with 99mTc tin colloid radiotracer lymphatic map-
ping in patients with squamous cell carcinoma of the oral
cavity identified at least one sentinel lymph node in 19 of 20
cases (95.0%) by lymphoscintigraphy and in all cases (100%)
by intraoperative gamma probing.
The number of sentinel nodes in each case ranged from one
to four with a mean of 2.55. The size of sentinel nodes ranged
from 0.8 to 1.5 cm (0.85±0.33 cm, mean±SD) in the short
axis and from 0.5 to 2.0 cm (1.33±0.60 cm, mean±SD)
in the long axis.
All sentinel nodes were found in the ipsilateral neck to pri-
mary tumors, mostly at cervical lymph node level II (95.0%)
followed by level III (55.0%) and level I (35.0%).
Frozen-section histological analyses according to our patho-
logic protocol accurately revealed the pathologic status of
the sentinel lymph node, as confirmed by hematoxylin-eosin
staining. Further tumor cells were not detected by cytoker-
atin AE1/AE3 immunohistochemical staining.
In 6 of 20 cases, the SLNBx procedure revealed the malig-
nant cells in the sentinel lymph nodes (the rate of occult meta-
stasis: 30.0%). Therefore, positive tumor cells in sentinel
nodes predicted N(+) accurately.
Moreover, there was no instance in which micrometastatic
disease was negative in the sentinel nodes while being posi-
tive in the remaining lymph nodes (negative predictive value:
100% and false negative rate: 0%)
DISCUSSION
SLNBx in head and neck cancer is becoming accepted as
useful in predicting the cervical nodal status for clinically
node negative neck. However, the application of SLNBx in
clinical settings requires several problems to be overcome,
including proving the technical feasibility of the procedure
used at each institute (which varies between institutions) and
achieving an acceptable identification rate of the sentinel node
and acceptable predictability for cervical nodal status (4).
In the first two cases in our series, we used a combination
of blue dye mapping and radiotracer injection. However, we
experienced difficulty in determining the precise location of
the blue-stained nodes before skin incision when using the
blue dye technique, resulting in unnecessary dissection (4,
8, 9). Moreover, the rate of identification and the prediction
rate of neck lymph node pathology of sentinel nodes has been
reported to be only 50-75%, making it difficult to accurately
select all first draining lymph nodes (4, 8) and the passage
time of blue dye is relatively too short (about 15 min) to allow
the procedure to be completed (4, 8). For these reasons, the
blue dye mapping technique was not used after the second
cases in our series.
In contrast, radiolocalization of the sentinel lymph node
is gaining popularity (11). In recent studies using radiotrac-
ers, the diagnostic accuracy and the localization rate reaches
almost 100% (9-11). The figures obtained from this study
correspond with other reports. At identifying the sentinel
nodes in node-negative oral cavity cancer patients, the detec-
tion rate ranged from 93.8% to 100% (3, 4, 7, 8, 11) in the
literature, which is similar to that of our method. Also the
diagnostic accuracy of predicting cervical nodal status by ana-
lyzing the sentinel lymph nodes in our study (100%) con-
firms the high predictability of earlier studies (94-100%) (7,
8, 11).
One problem occurs when the lymphatic bed being sur-
veyed is immediately adjacent to the primary lesion contain-
ing injected radionuclide. To avoid this problem, we first ex-
cised the primary tumor with an adequate safety margin before
identifing sentinel nodes using a hand-held gamma probe,
which was easily achieved due to the absence of radioactivi-
ty interference from the injected site.
There are several 99mTc labeled radiocolloids reported in the
literature, but as the materials licensed for use in Korea are
limited, 99mTc filered tin colloid was selected for this study.
99mTc tin colloids were filtered into its relatively regular par-
ticle size (≤200 nm), because smaller particle colloids tend
to be faster moving, and in case of disease present within the
sentinel node, larger particles are less likely to penetrate into
the sentinel node, so have a chance not to detect it (8, 11, 12).
A literature also reported that smaller sized 99mTc tin colloids
were slightly superior to the regular sized 99mTc tin colloids
in the identification of sentinel nodes (97.3% vs. 86.5%) (12,
13). We found that 99mTc filtered tin colloid is an alternative
radiotracer that produces reliable results.
The assistance of a qualified nuclear medicine physician was
essential for the handling of the radioisotope and for inter-
pretation of the lymphoscintigraphic imaging. In this study,
we gave some modifications to the injection time and the
amount of radiotracer. 
On the day prior to surgery, the tracer was injected around
the primary tumor, instead of in the morning on the day ofSentinel Lymph Node Biopsy in Oral Cavity Cancer 869
surgery. The amount of 99mTc filtered tin colloid radiotracer
in this study was 5-6 mCi in contrast to that of other reports
(1-2 mCi) (3, 4, 7-9). With its half-life of about 6 hr, 1-1.5
mCi of radiotracer remained in the tissue on the following
morning, which is similar to several other reports. Our mod-
ifications of a delay of 12-20 hr between the injection of 99mTc
filtered tin colloid and the application of SLNBx have a major
advantage in giving sufficient time to get more static images,
which effectively identified the sentinel lymph node during
lymphoscintigraphy and intraoperative gamma probing in
all patients.
As discussed by Byers et al., another concern in SLNBx is
whether this technique will detect ‘skip metastasis’ with acce-
ptable identification rate (14). Recently, the concept of ‘skip
metastasis’ is being redefined as skip metastasis may repre-
sent non-standard but sequential or multiple drainages of an
individual neck in parallel array (9, 15). According to this
explanation, the sentinel node will always be the initial site
of micrometastasis, and the evaluation of the histological sta-
tus of the sentinel node may help to predict the incidence of
regional micrometastasis in head and neck squamous cell car-
cinoma.
If a reliable assessment of the sentinel lymph nodes could
be made with frozen section biopsy, a decision regarding elec-
tive neck dissection would be possibly made at the time of
SLNBx and unnecessary surgeries could be avoided with safe
oncological results. Frozen section analysis may be a rate-lim-
iting step for SLNBx as the determining factor in concurrent
elective neck dissection. We believe that the data regarding
frozen sectioning should be added to the ongoing study.
Recent meta-analysis across the world reported that the
SLNBx procedure has shown high sensitivity rates for oral
squamous cell carcinomas and is reliable and reproducible
(16, 17), which we also reconfirmed through this study by
the validation of our technique. Now, SLNBx procedure seems
to be sufficiently validated, though it requires further refine-
ment of intra-operative frozen section analysis (18, 19). Trial
of SLNBx procedure as a sole method for neck management
also showed a promising result with a high diagnostic accu-
racy (83.3%), which could spare unnecessary neck dissection
in patients with no evidence of metastasis in the sentinel lymph
nodes (19). Through subsequent clinical trials, the authors
think that the SLNBx procedure can achieve its position firm-
ly as a useful and effective method for clinically node nega-
tive oral cancer.
In conclusion, our techniques of lymphoscintigraphy and
SLNBx using 99mTc filtered tin colloid in squamous cell car-
cinomas of the oral cavity were technically feasible and iden-
tified the sentinel node in all cases. The histological evalua-
tion of sentinel nodes according to our protocol provided the
exact reflections of cervical nodal status. This study could guide
as the primary protocol of SLNBx procedure for clinical trials
if the results of further study corroborate the data presented
here.
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